Heterologous protein production using euchromatin-containing expression vectors in mammalian cells

• Published in: Nucleic acids research Vol. 43; no. 16; p. e102
• Main Authors: Zboray, Katalin, Sommeregger, Wolfgang, Bogner, Edith, Gili, Andreas, Sterovsky, Thomas, Fauland, Katharina, Grabner, Beatrice, Stiedl, Patricia, Moll, Herwig P, Bauer, Anton, Kunert, Renate, Casanova, Emilio
• Format: Journal Article
• Language: English
• Published: England Oxford University Press 18.09.2015
• Subjects: Animals; Antibodies, Neutralizing - biosynthesis; Antibodies, Neutralizing - genetics; CHO Cells; Chromosomes, Artificial, Bacterial; Cricetinae; Cricetulus; Euchromatin; Genetic Vectors; Glycoproteins - biosynthesis; Glycoproteins - genetics; HIV Antibodies - biosynthesis; HIV Antibodies - genetics; HIV-1 - genetics; HIV-1 - immunology; Human immunodeficiency virus 1; Human Immunodeficiency Virus Proteins - biosynthesis; Human Immunodeficiency Virus Proteins - genetics; Humans; Immunoglobulin Fc Fragments - biosynthesis; Immunoglobulin Fc Fragments - genetics; Methods Online; Recombinant Proteins - biosynthesis; Recombinant Proteins - genetics
• ISSN: 0305-1048; 1362-4962
• DOI: 10.1093/nar/gkv475

Upon stable cell line generation, chromosomal integration site of the vector DNA has a major impact on transgene expression. Here we apply an active gene environment, rather than specified genetic elements, in expression vectors used for random integration. We generated a set of Bacterial Artificial Chromosome (BAC) vectors with different open chromatin regions, promoters and gene regulatory elements and tested their impact on recombinant protein expression in CHO cells. We identified the Rosa26 BAC as the most efficient vector backbone showing a nine-fold increase in both polyclonal and clonal production of the human IgG-Fc. Clonal protein production was directly proportional to integrated vector copy numbers and remained stable during 10 weeks without selection pressure. Finally, we demonstrated the advantages of BAC-based vectors by producing two additional proteins, HIV-1 glycoprotein CN54gp140 and HIV-1 neutralizing PG9 antibody, in bioreactors and shake flasks reaching a production yield of 1 g/l.